Global joint pain injections market projected to reach $9.46 billion by 2031

From GlobeNewswire: 2024-07-16 09:04:00

The global Joint Pain Injections Market is projected to reach $9.46 billion by 2031, growing at a CAGR of 8.7%. Rising geriatric population and advancements in injectable drugs are driving market growth. Hyaluronic acid injections and stem cell therapy are gaining popularity for long-lasting pain relief and promoting joint healing. Steroid injections remain popular for quick pain relief, especially in knee and shoulder joints.

North America is expected to dominate the joint pain injections market, driven by rising obesity rates and the growing geriatric population. Knee and ankle joint injections are anticipated to lead the market due to high incidence of knee osteoarthritis. Leading players like Zimmer Biomet and Bioventus are focusing on new product launches and geographical expansion to strengthen their market position.

Recent developments include Green Roads donating $120,000 to the Arthritis Foundation and AbbVie receiving FDA approval for SKYRIZI for adults with psoriatic arthritis. The market is segmented by injection type, joint type, distribution channel, and region. With a focus on providing actionable insights, Coherent Market Insights aims to deliver reliable and authentic reports across various industries for post-COVID-19 recovery.



Read more at GlobeNewswire: Joint Pain Injections Market Size to reach $9.46 billion by